These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 24237253

  • 1. Erythroid and megakaryocytic differentiation of K562 erythroleukemic cells by monochloramine.
    Ogino T, Kobuchi H, Fujita H, Matsukawa A, Utsumi K.
    Free Radic Res; 2014 Mar; 48(3):292-302. PubMed ID: 24237253
    [Abstract] [Full Text] [Related]

  • 2. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
    Yi ZC, Wang Z, Li HX, Liu MJ, Wu RC, Wang XH.
    Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
    [Abstract] [Full Text] [Related]

  • 3. CDDO-Im is a stimulator of megakaryocytic differentiation.
    Petronelli A, Pelosi E, Santoro S, Saulle E, Cerio AM, Mariani G, Labbaye C, Testa U.
    Leuk Res; 2011 Apr; 35(4):534-44. PubMed ID: 21035854
    [Abstract] [Full Text] [Related]

  • 4. The alpha1-adrenergic receptor antagonists, benoxathian and prazosin, induce apoptosis and a switch towards megakaryocytic differentiation in human erythroleukemia cells.
    Fuchs R, Stelzer I, Haas HS, Leitinger G, Schauenstein K, Sadjak A.
    Ann Hematol; 2009 Oct; 88(10):989-97. PubMed ID: 19241077
    [Abstract] [Full Text] [Related]

  • 5. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
    Akel S, Bertolette D, Petrow-Sadowski C, Ruscetti FW.
    Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647
    [Abstract] [Full Text] [Related]

  • 6. A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis.
    Liu T, Yao Y, Zhang G, Wang Y, Deng B, Song J, Li X, Han F, Xiao X, Yang J, Xia L, Li YJ, Plachynta M, Zhang M, Yan C, Mu S, Luo H, Zacksenhaus E, Hao X, Ben-David Y.
    Oncotarget; 2017 Mar 07; 8(10):16728-16743. PubMed ID: 28052010
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Induced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: a novel experimental model for hemopoietic lineage restriction.
    Green AR, Rockman S, DeLuca E, Begley CG.
    Exp Hematol; 1993 Apr 07; 21(4):525-31. PubMed ID: 8462662
    [Abstract] [Full Text] [Related]

  • 9. Expression of megakaryocytic and erythroid properties in human leukemic cells.
    Tani T, Ylänne J, Virtanen I.
    Exp Hematol; 1996 Feb 07; 24(2):158-68. PubMed ID: 8641337
    [Abstract] [Full Text] [Related]

  • 10. Erk pathway inhibitor U0126 induces gamma-globin expression in erythroid cells.
    McElveen RL, Lou TF, Reese K, Xia S, Baliga BS, Pace BS.
    Cell Mol Biol (Noisy-le-grand); 2005 Sep 05; 51(2):215-27. PubMed ID: 16171557
    [Abstract] [Full Text] [Related]

  • 11. Oral small-molecule tyrosine kinase inhibitor midostaurin (PKC412) inhibits growth and induces megakaryocytic differentiation in human leukemia cells.
    Huang YC, Chao DK, Clifford Chao KS, Chen YJ.
    Toxicol In Vitro; 2009 Sep 05; 23(6):979-85. PubMed ID: 19573588
    [Abstract] [Full Text] [Related]

  • 12. AP-1 regulates alpha2beta1 integrin expression by ERK-dependent signals during megakaryocytic differentiation of K562 cells.
    Eriksson M, Arminen L, Karjalainen-Lindsberg ML, Leppä S.
    Exp Cell Res; 2005 Mar 10; 304(1):175-86. PubMed ID: 15707584
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of K562 cells.
    Yuan JY, Wang F, Yu J, Yang GH, Liu XL, Zhang JW.
    J Cell Mol Med; 2009 Mar 10; 13(11-12):4551-9. PubMed ID: 19017354
    [Abstract] [Full Text] [Related]

  • 14. α1-Adrenergic drugs modulate differentiation and cell death of human erythroleukemia cells through non adrenergic mechanism.
    Fuchs R, Schraml E, Leitinger G, Stelzer I, Allard N, Haas HS, Schauenstein K, Sadjak A.
    Exp Cell Res; 2011 Oct 01; 317(16):2239-51. PubMed ID: 21781962
    [Abstract] [Full Text] [Related]

  • 15. Identification and characterization of a novel zinc finger protein (HZF1) gene and its function in erythroid and megakaryocytic differentiation of K562 cells.
    Peng H, Du ZW, Zhang JW.
    Leukemia; 2006 Jun 01; 20(6):1109-16. PubMed ID: 16628192
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro dual effect of arsenic trioxide on hemopoiesis: inhibition of erythropoiesis and stimulation of megakaryocytic maturation.
    Saulle E, Riccioni R, Pelosi E, Stafness M, Mariani G, De Tuglie G, Peschle C, Testa U.
    Blood Cells Mol Dis; 2006 Jun 01; 36(1):59-76. PubMed ID: 16360329
    [Abstract] [Full Text] [Related]

  • 18. Staurosporine induces megakaryocytic differentiation through the upregulation of JAK/Stat3 signaling pathway.
    Peng HY, Liao HF.
    Ann Hematol; 2011 Sep 01; 90(9):1017-29. PubMed ID: 21331591
    [Abstract] [Full Text] [Related]

  • 19. Decay of globin mRNA during megakaryocytic differentiation of erythroleukemic cell line is accomplished through shortening of the poly(A) tail and degradation from the 3' end of the transcript.
    Lumelsky NL.
    Biochim Biophys Acta; 1995 Apr 04; 1261(2):265-71. PubMed ID: 7711070
    [Abstract] [Full Text] [Related]

  • 20. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase.
    Whalen AM, Galasinski SC, Shapiro PS, Nahreini TS, Ahn NG.
    Mol Cell Biol; 1997 Apr 04; 17(4):1947-58. PubMed ID: 9121442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.